Bio-Connect
IHC-P analysis of human brain tissue using GTX85405 CAPS2 antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85405 CAPS2 antibody. Working concentration : 5 microg/ml
IHC-P analysis of human brain tissue using GTX85405 CAPS2 antibody. Working concentration : 5 microg/ml

CAPS2 antibody

GTX85405
GeneTex
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetCADPS2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    CAPS2 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 0.5 - 1 microg/mL. IHC-P: 5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID93664
  • Target name
    CADPS2
  • Target description
    calcium dependent secretion activator 2
  • Target synonyms
    CAPS2, calcium-dependent secretion activator 2, CAPS-2, Ca++-dependent secretion activator 2, Ca2+ dependent secretion activator 2, Ca2+-dependent activator protein for secretion 2, calcium-dependent activator protein for secretion 2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ86UW7
  • Protein Name
    Calcium-dependent secretion activator 2
  • Scientific Description
    CAPS2 and the related protein CAPS1 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins. Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles; CAPS-deficient neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release. Like CAPS1, numerous isoforms of CAPS2 are known to exist. These isoforms show distinct expression patterns in the brain. For example, CAPS2b showed high expression in the developing cerebellum. Furthermore, one version of CAPS2 mRNA that lacks exon 3 is detected in some autistic patients, suggesting that the differential expression pattern of CAPS2 is involved in neuronal development. This CAPS2 antibody is predicted to be specific to CAPS2 and not recognize CAPS1.
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203